Cannabis and anxiety
Anxiety disorders are the same in Oregon as anywhere, and they are among the most common reasons people say they use cannabis. Oregon's qualifying list does not include them, and that list is closed — it changes by statute or by a formal petition, not by a provider's judgement. In Oregon that matters less than it sounds, because anyone 21 or over can buy without a card at all. So the question this page is about is not whether you can get it. It is whether it does what people reach for it to do, and controlled research has not shown that it does.
Some people feel calmer; others get anxious, paranoid or racing. Controlled research has not established cannabis as a treatment for any anxiety disorder.
- A short-term reduction in subjective distress at a low oral THC dose in a laboratory setting
- Anxiety, panic and paranoia as common effects of THC in other people
- That cannabinoids treat any anxiety disorder; the most recent randomised evidence found no significant effect
- That a dose can be aimed at anxiety — a higher dose worsened mood in the same study
- That retail CBD products are established anxiety medicines
- That products marketed as calming carry any treatment evidence
If you decide to look into it in Oregon
Anxiety disorders are not standalone qualifying conditions in Oregon, and that is not an oversight anyone is about to correct informally. The qualifying list is a closed enumeration in ORS 475C.777. It changes only by statute or through a formal petition under OAR 333-008-0090 — and OHA's most recently published final order on such a petition was a denial.
There is one indirect route: if a diagnosed condition, or its treatment, produces severe pain, severe nausea, seizures or persistent muscle spasms, that qualifies. PTSD qualifies in its own right. So a person with anxiety alongside one of those may well have a card — for the other condition.
For everyone else, Oregon's adult-use system is the access story: 21 and over, no card, 730 licensed retailers. What the card would have added is the 17% state tax exemption and residential delivery anywhere in the state, which adult-use buyers cannot get because no Oregon jurisdiction has opted into cross-border delivery.
Can cannabis help anxiety, or make it worse?
The short answer. Both experiences are real, and controlled research has not established cannabis as a treatment for any anxiety disorder. The most recent randomised evidence found no significant effect on anxiety outcomes at all.
What the treatment trials show. A 2026 Lancet Psychiatry systematic review and meta-analysis examined 54 randomised trials with 2,477 participants, testing cannabinoids as treatment for mental disorders and substance use disorders. It found no significant effects on anxiety outcomes. Its overall conclusion: "Given the scarcity of evidence, the routine use of cannabinoids for the treatment of mental disorders and SUDs is currently rarely justified." Where that review did find signals of benefit, they were for cannabis use disorder, insomnia, Tourette's and autism — not for anxiety. It also found cannabinoids raised the odds of all-cause adverse events, with a number-needed-to-harm of 7.
A second 2026 review reached a softer-sounding conclusion that does not survive its own caveats. Pooling a broader mix of studies, it reported reduced anxiety symptoms (SMD −0.40, 95% CI −0.57 to −0.23) — but at very low certainty, with heterogeneity of I² = 90%, and drawing substantially on secondary outcomes measured in people whose primary condition was something else. Its own summary: the evidence "is insufficient to support cannabinoids as first-line treatment."
Why the everyday experience is genuinely contradictory. In a randomised laboratory study of 42 healthy volunteers, 7.5 mg of oral THC reduced self-reported distress after a social stress test, while 12.5 mg increased negative mood — but the higher dose raised negative mood both before and throughout the tasks, so this is a general dysphoric effect rather than a stress-specific one. The same dose also impaired performance on the task. With roughly fourteen people per arm, this is a mechanism illustration, not a dosing finding, and nobody should read a milligram target out of it.
THC and CBD are not interchangeable. THC drives intoxication and can provoke anxiety, particularly at higher exposure. CBD does not produce the same intoxication and has been studied separately, but retail CBD products vary widely in dose and formulation and are not established anxiety medicines.
What guidance and evidence say
- Wilson J, Dobson O, Langcake A, et al. Lancet Psychiatry. 2026;13(4):304-315. doi:10.1016/S2215-0366(26)00015-5 (corrected 16 June 2026)
- Bharat C, Huang X, Campbell G, et al. Psychiatry Res. 2026;365:117380. doi:10.1016/j.psychres.2026.117380
- Childs E, Lutz JA, de Wit H. Drug Alcohol Depend. 2017;177:136-144. doi:10.1016/j.drugalcdep.2017.03.030
Most clinical evidence on cannabis comes from trials of pharmaceutical cannabinoids at measured doses. Very little tested smoked flower, vapes or edibles at dispensary potencies. When research is described as relevant to a use, it is usually not the product you would buy.
Check your medications first
Cannabis and prescription medicines
This page has not been reviewed by a clinician. It summarises published research about cannabis and cannabinoids, with sources listed at the bottom of the page. Cannabis research usually tests standardised pharmaceutical preparations that differ substantially from anything sold in a shop, and the presence of research about a condition does not mean cannabis is an approved treatment for it. Nothing here is medical advice, and no one should start, stop or change any treatment based on it. Those decisions belong with a qualified healthcare professional who knows your situation.